Please login to the form below

Not currently logged in
Email:
Password:

Regeneron taps Pfizer for CFO

Robert Landry succeeds Murray Goldberg

Robert Landry, Regeneron Former Pfizer senior VP Robert Landry has joined Regeneron as senior VP, finance, and will later take over as chief financial officer.

Landry (pictured) was most recently senior VP and treasurer at Pfizer having joined the company in 2009 as senior VP, finance.

Prior to his time at Pfizer, he was treasurer at Wyeth, which was acquired by Pfizer in 2009. He was also previously chief financial officer for Wyeth's Australian and New Zealand affiliates.

Landry assumes the role of senior VP at Regeneron immediately and will succeed Murray Goldberg as chief financial officer on October 1 when Goldberg steps after 18 years with Regeneron.

Meanwhile, Goldberg will transition to a new role as senior VP, administration, in anticipation of his full retirement at the end of 2014.

Reporting to CEO Dr Leonard Schleifer, Landry will have responsibility for all financial functions, including treasury, financial planning, tax, and internal audit.

"We are extremely fortunate that Murray will stay at Regeneron through 2014 to help us with the transition to a new chief financial officer," said Dr Schleifer.

"Bob Landry brings with him a breadth of domestic and international financial expertise at Pfizer and Wyeth. We look forward to the valuable perspective he will bring, as we continue to expand our operations in the US and globally."

17th September 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...